History
  • No items yet
midpage
Feldman's Medical Center Pharmacy, Inc. v. CareFirst, Inc.
898 F. Supp. 2d 883
D. Maryland
2012
Read the full case

Background

  • ERISA case; FMCP seeks attorney’s fees and costs after judgment disposing of fee issue; Court denied fees.
  • FMCP supplied factor drugs for CareFirst insureds; dispute centered on PPP/participating provider status and RSA licensure.
  • CareFirst alleged FMCP lacked RSA license for home infusion/infusion therapy and thus was not entitled to factor drug payments.
  • CareFirst eventually paid the disputed claims after Maryland Board of Pharmacy opinions; FMCP had drop-shipped factors rather than home infusion.
  • Court previously held FMCP not a participating provider under PPP but valid assignee of insureds’ rights and awarded prejudgment interest under ERISA; later decision denied fee request.
  • Adverse party positions included extensive regulatory/licensing confusion and bureaucratic miscommunication rather than bad faith as found by the Court.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Whether FMCP may recover attorney’s fees under ERISA §1132(g)(1). FMCP achieved some success and catalyst effect. No substantial success under Hardt; catalyst theory not warranted. FMCP not entitled to fees under ERISA.
Whether the catalyst theory applies to ERISA fee awards post-Hardt. Catalyst theory supports fees for prompting relief. Catalyst theory doubtful; need substantial change in legal relationship. Catalyst theory not proven to apply here.
Whether FMCP achieved “some success on the merits” under Hardt through the court’s adjudication. Court’s partial prejudgment interest constitutes success. No meritorious judicial determination; relief was procedural. Hardt not satisfied; no some-success on merits.
Whether the Ohio River factors apply to ERISA catalyst analysis. Ohio River framework appropriate for catalyst under ERISA. Similar to SMCRA, but not necessarily required. Ohio River framework applied to evaluate the catalyst claim.
Whether FMCP’s claimed prejudgment interest or costs are recoverable. Interest and costs should be awarded. Interests/costs not warranted given outcome. Award denied; no costs or fees awarded.

Key Cases Cited

  • Hardt v. Reliance Standard Life Ins. Co., 560 U.S. 242 (U.S. 2010) (adopts ‘some degree of success on the merits’ standard under ERISA)
  • Buckhannon Bd. & Care Home v. W. Va. Dept. of Health & Human Res., 532 U.S. 598 (U.S. 2001) (catalyst theory analysis limited by ‘prevailing party’ context)
  • Ruckelshaus v. Sierra Club, 463 U.S. 680 (U.S. 1983) (origin of ‘some degree of success on the merits’ standard)
  • Ohio River Valley Environmental Coalition, Inc. v. Green Valley Coal Co., 511 F.3d 407 (4th Cir. 2007) (three-threshold catalyst framework used in ERISA context)
  • Sarangrella v. Group Health, Inc., 877 F. Supp. 2d 78 (S.D.N.Y. 2012) (catalyst theory rejected for ERISA fee awards in some rulings)
  • Taaffe v. Life Ins. Co.,, 769 F. Supp. 2d 530 (S.D.N.Y. 2011) (fee award considerations under catalyst theory in ERISA)
  • Flores v. Life Ins. Co. of N. Am., 770 F. Supp. 2d 768 (D. Md. 2011) (catalyst theory used to find some success on the merits)
  • Nadeau v. Helgemoe, 581 F.2d 275 (1st Cir. 1978) (catalyst notion origin in Buckhannon lineage)
Read the full case

Case Details

Case Name: Feldman's Medical Center Pharmacy, Inc. v. CareFirst, Inc.
Court Name: District Court, D. Maryland
Date Published: Sep 28, 2012
Citation: 898 F. Supp. 2d 883
Docket Number: Civil No. SKG-10-254
Court Abbreviation: D. Maryland